Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 2 3

Status

Active not recruiting 3Recruiting 2Not yet recruiting 1

Sponsor Class

NIH 3OTHER 2NETWORK 1

Study Type

Interventional 6

Sponsor

Cancer Type

Other solid neoplasm 6

Conditions

Breast Neoplasms 395Neoplasms 350Carcinoma, Non-Small-Cell Lung 313Prostatic Neoplasms 264Colorectal Neoplasms 236Lung Neoplasms 204Multiple Myeloma 163Pancreatic Neoplasms 147Ovarian Neoplasms 146Neoplasm Metastasis 141Leukemia, Myeloid, Acute 138Melanoma 118Squamous Cell Carcinoma of Head and Neck 100Carcinoma, Renal Cell 93Stomach Neoplasms 92Recurrence 92Lymphoma 91Lymphoma, Non-Hodgkin 89Endometrial Neoplasms 89Carcinoma, Hepatocellular 89Precursor Cell Lymphoblastic Leukemia-Lymphoma 87Glioblastoma 85Brain Neoplasms 84Head and Neck Neoplasms 77Glioma 76Uterine Cervical Neoplasms 75Urinary Bladder Neoplasms 72Sarcoma 70Leukemia, Lymphocytic, Chronic, B-Cell 70Hematologic Neoplasms 68

Interventions

Specimen Handling 3Biopsy 3X-Rays 2Standard of Care 2Practice Guidelines as Topic 2Interviews as Topic 2trastuzumab biosimilar HLX02 1pertuzumab 1erdafitinib 1copanlisib 1Trastuzumab 1Palliative Care 1PF-05280014 1Ontruzant 1Ogivri 1Methods 1Magnetic Resonance Spectroscopy 1Health Promotion 1Educational Status 1Early Intervention, Educational 1CT-P6 12C4 antibody 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Malignant Solid Neoplasm × 30 days × Clear all
NCT06136897 2026-05-29

Testing Trastuzumab and Pertuzumab in Patients With Higher Than Normal Copies of the HER2 Gene Found in Their Tumors (MATCH - Subprotocol J)

National Cancer Institute (NCI)

Phase 2 Active not recruiting
35 enrolled 10 charts
Other solid neoplasm

Malignant Solid Neoplasm

NCT06351371 2026-05-28

Testing JNJ-42756493 (Erdafitinib) as Potentially Targeting Treatment in Cancers With FGFR Mutations or Fusions (MATCH - Subprotocol K2)

National Cancer Institute (NCI)

Phase 2 Active not recruiting
35 enrolled 10 charts
Other solid neoplasm

Malignant Solid Neoplasm

NCT06360588 2026-05-28

Testing Copanlisib as Potentially Targeting Treatment in Cancers With PTEN Loss (MATCH - Subprotocol Z1G)

National Cancer Institute (NCI)

Phase 2 Active not recruiting
22 enrolled 9 charts
Other solid neoplasm

Malignant Solid Neoplasm

NCT06541158 2026-05-28

TRACT

Emory University

Phase NA Recruiting
76 enrolled
Other solid neoplasm

Malignant Solid Neoplasm

NCT06771739 2026-05-22

A Pilot Unrestricted Payment Program for Early-stage Cancer Patients: the PAYMENT Trial

Fred Hutchinson Cancer Center

Phase NA Not yet recruiting
20 enrolled
Other solid neoplasm

Malignant Solid Neoplasm

NCT06295367 2026-05-15

Cost Communication and Financial Navigation in Cancer Patients (COSTCOM)

Eastern Cooperative Oncology Group

Phase NA Recruiting
760 enrolled
Other solid neoplasm

Malignant Solid Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡